The authors further discussed that the high odds of overweight and obesity in this population may be attributed to the weight-gaining side effects of certain medications, specifically thiazonlinedione and sulphonylureas when coupled with insulin. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.